Study finds higher death rate in calorie-restricted models of IBD

In a surprising result, Michigan State University researchers looking at the effects of diet on bowel disease found that mice on a calorie-restricted diet were more likely to die after being infected with an inflammation-causing bacterial pathogen in the colon.

While research suggests inflammation associated with obesity may contribute to inflammatory bowel diseases such as colitis, the study results revealed a low-calorie diet may actually impair the immune system's ability to respond to infection, said Jenifer Fenton, assistant professor in the Department of Food Science and Human Nutrition.

Additionally, the study found no connection that moderate obesity increased the severity of colitis in the mouse model.

"The results are similar to the research from our department that shows consuming fewer calories make it harder to fight off the flu virus," said Fenton, referring to recent work by colleague Elizabeth Gardner. "Since this is a totally different pathogen, it amplifies the need to find out why caloric intake has such an impact on the body's ability to respond to infection.

"It is possible that the same mechanism that happens with the flu is occurring with gastro-intestinal diseases; future research will ask this very question."

The research is published in the current edition of the World Journal of Gastroenterology.

Inflammatory bowel disease, or IBD, is a group of conditions affecting the colon and intestines; the major types being ulcerative colitis and Crohn's disease. People suffering from IBD have an increased risk of developing colon cancer.

As part of their study, Fenton and colleagues evaluated the influence of obesity and calorie-restricted diets on mice with induced colitis.

Mice in the study were given one of three dietary treatments: a high-fat diet, a 30 percent caloric-restriction diet and a control group on an average-caloric diet. They then were treated with bacteria called H. hepaticus, which infects the colon and causes inflammation, eventually leading to tumor development. This process models the more aggressive lesions observed in human colon cancer cases.

Unexpectedly, study results suggest increased body fat induced by a high-fat diet did not influence the severity of colitis, despite changes in hormones that are known to increase with obesity and influence inflammation. In fact, researchers found calorie-restricted mice had a higher mortality rate in response to infection with H. hepaticus, dying before tumors even developed.

"Future studies should examine the association between body fat percentage and immune responses to infections leading to inflammatory bowel diseases," Fenton said. "Understanding how a low-calorie diet increases mortality in this model may lead to new treatments for the disease in humans."

Source: Michigan State University

Comments

  1. Richard Carlson Richard Carlson United States says:

    Excellent work that, as suggested, demands further work!
    The fact that both bacterial and viral pathogens, in separate studies, are showing similar results is indeed intriguing.

    PS: Perhaps some of the surprise in the "surprising result" stems from a "thin is in" cultural bias (we tend to supply a halo on all things "low-calorie").

    Richard Carlson

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New pro-oxidant supplement shows promise in slowing prostate cancer progression